In response, a trade group representing compounding pharmacies is suing the FDA
Diindolylmethane (DIM) spontaneously forms from indole-3-carbinol (I3C) during cell culture experiments
While this may not be true for EACH and EVERY person, its still worth considering
Regular use can help to reduce the bodys toxins load
Supporting this notion, GLP-1 RAs are reported to decrease reactive oxygen species production in endothelial cells, reduce circulating markers of inflammation, and slow atherosclerotic plaque formation by inhibiting the expression of adhesion molecules [43, 52]
Approvals for the immunotherapies Keytruda (-PD-1 mAb) and Kymriah (CD19 CAR-T) were turning points in the fight against cancerthese successes paved the way for dozens of other biotechs and large pharma to develop their own PD-1- or CD19-targeting agents